{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:50:37Z","timestamp":1775710237090,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize the clinical features and genetic variation spectrum of children with paroxysmal kinesigenic dyskinesia (PKD) admitted to the Children\u2019s Medical Center of Union Hospital Affiliated to Fujian Medical University and to provide references for clinical diagnosis and genetic counseling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on the clinical data of 6 pediatric patients diagnosed with PKD in our hospital from November 2018 to August 2025. The data included medical history, triggering factors, clinical manifestations, auxiliary examinations, and treatment responses. Whole-exome sequencing (WES) was employed to detect gene mutations, followed by Sanger sequencing for verification. The pathogenicity of the identified variants was assessed according to the guidelines of the American College of Medical Genetics and Genomics (ACMG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study cohort included 5 males and 1 female, with an age of onset ranging from 5 to 12\u202fyears. Two cases were familial, while four were sporadic. All paroxysmal episodes were induced by sudden movement, postural change, or anxiety. The clinical manifestations included unilateral or bilateral limb posturing, tremor, athetosis, dystonia, and weakness, without impairment of consciousness. The attacks were brief (duration \u226450\u202fs) and occurred with a frequency ranging from 1-2 per month to 5-6 per day. A history of febrile seizures was present in three patients. The magnetic resonance imaging (MRI) scan of the brain of one child showed a lacune in the right frontal lobe, and video electroencephalogram (VEEG) of another child revealed abnormal epileptic discharges during the interictal period. Genetic analysis via whole-exome sequencing (WES) identified pathogenic variants in all six patients: five harbored\n                      <jats:italic>PRRT2<\/jats:italic>\n                      mutations (including point mutations c.649dupC, c.972delA, and c.1141delC, or exon deletions), and one had a\n                      <jats:italic>KCNMA1<\/jats:italic>\n                      mutation (c.946G&amp;gt;A). Regarding treatment, four patients administered low-dose carbamazepine and two received low-dose oxcarbazepine, all of whom achieved complete or substantial control of the dyskinetic attacks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The clinical features of pediatric PKD align with typical paroxysmal manifestations. The\n                      <jats:italic>PRRT2<\/jats:italic>\n                      gene is the primary pathogenic gene, although cases associated with\n                      <jats:italic>KCNMA1<\/jats:italic>\n                      mutations were also identified. Both carbamazepine and oxcarbazepine demonstrated efficacy in treating childhood PKD. Genetic testing facilitates definitive diagnosis and genetic subtyping.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1788601","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:15:35Z","timestamp":1775708135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and genetic analysis of paroxysmal kinesigenic dyskinesia in children"],"prefix":"10.3389","volume":"17","author":[{"given":"Li-ping","family":"Zheng","sequence":"first","affiliation":[{"name":"Fujian Medical University Union Hospital","place":["Fuzhou, China"]},{"name":"Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-peng","family":"Ye","sequence":"additional","affiliation":[{"name":"Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xia","family":"Lin","sequence":"additional","affiliation":[{"name":"Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1212\/01.wnl.0000147298.05983.50","article-title":"Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-021-00231-8","article-title":"Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China","volume":"10","author":"Cao","year":"2021","journal-title":"Transl Neurodegener"},{"key":"ref3","first-page":"321","article-title":"Clinical features and video-EEG analysis of 4 cases with paroxysmal kinesigenic dyskinesia","volume":"19","author":"Chen","year":"2024","journal-title":"Neural Injury Funct Reconst"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4103\/0028-3886.185413","article-title":"Paroxysmal kinesigenic dyskinesia: a frequently misdiagnosed movement disorder","volume":"64","author":"Pandey","year":"2016","journal-title":"Neurol India"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/ng.1008","article-title":"Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mds.27274","article-title":"Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: clinical and genetic analyses of 163 patients","volume":"33","author":"Tian","year":"2018","journal-title":"Mov Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"ref8","first-page":"9","article-title":"Diagnosis and treatment of paroxysmal movement induced dysfunction in China","volume":"55","author":"Wu","year":"2022","journal-title":"Chin J Neurol"},{"key":"ref9","first-page":"206","article-title":"Clinical phenotypes of paroxysmal kinesigenic dyskinesia with PRRT2 c.649dupC mutation","volume":"48","author":"Liu","year":"2022","journal-title":"Chinese J Nerv Mental Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0b013e3182661fe3","article-title":"PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions","volume":"79","author":"van Vliet","year":"2012","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s12264-023-01157-z","article-title":"Paroxysmal kinesigenic dyskinesia: genetics and pathophysiological mechanisms","volume":"40","author":"Xu","year":"2024","journal-title":"Neurosci Bull"},{"key":"ref12","first-page":"1427","article-title":"Research advances in paroxysmal kinesigenic dyskinesia","volume":"28","author":"Li","year":"2013","journal-title":"Chinese J Appl Clin Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1007\/s00415-022-11103-0","article-title":"Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia","volume":"269","author":"Liu","year":"2022","journal-title":"J Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.28061","article-title":"The phenotypic and genetic spectrum of paroxysmal kinesigenic dyskinesia in China","volume":"35","author":"Huang","year":"2020","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"629747","DOI":"10.3389\/fneur.2021.629747","article-title":"The spectrum of PRRT2-associated disorders: update on clinical features and pathophysiology","volume":"12","author":"Landolfi","year":"2021","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.0000000000002079","article-title":"Paroxysmal kinesigenic dyskinesia: clinical and genetic analyses of 110 patients","volume":"85","author":"Huang","year":"2015","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/jnnp-2018-318932","article-title":"Unravelling of the paroxysmal dyskinesias","volume":"90","author":"Erro","year":"2019","journal-title":"J Neurosurg Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1093\/brain\/awr289","article-title":"Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias","volume":"134","author":"Wang","year":"2011","journal-title":"Brain"},{"key":"ref19","first-page":"124","article-title":"Advances in neural circuitry research of paroxysmal kinesigenic dyskinesia","volume":"23","author":"Li","year":"2023","journal-title":"Chin J Contemp Neurol Neurosurg"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1093\/brain\/awv310","article-title":"The clinical and genetic heterogeneity of paroxysmal dyskinesias","volume":"138","author":"Gardiner","year":"2015","journal-title":"Brain"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/19336950.2021.1938852","article-title":"An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy","volume":"15","author":"Miller","year":"2021","journal-title":"Channels (Austin)"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1788601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:15:38Z","timestamp":1775708138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1788601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":21,"alternative-id":["10.3389\/fneur.2026.1788601"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1788601","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"article-number":"1788601"}}